In recent years, clinical studies found that GLP-1 receptor agonist (GLP-1 RAs) and its analogues can significantly improve bone metabolism in diabetes patients, promoting osteoblastic differentiation, and play an anti-diabetic osteoporosis role (7). This evidence concerns the gene GLP1R and diabetes mellitus.